MedTrace Logo

Phase 2 Study in Adults Sensitized to Cat

NCT00689299 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 167

Last updated 2014-05-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to identify an effective dose of allergen-specific immunotherapy for cat hair (Felis domesticus) administered by the oral/sublingual route.

Conditions

  • Allergy

Interventions

BIOLOGICAL

Standardized Allergenic Extract, Cat Hair

Standardized Cat Hair Allergenic Extract sublingual drops

BIOLOGICAL

Placebo

Placebo Sublingual Drops

Sponsors & Collaborators

  • Antigen Laboratories, Inc.

    lead INDUSTRY

Principal Investigators

  • Robert B. Berkowitz, M.D. · Allergen Response Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-05-31
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00689299 on ClinicalTrials.gov